The efficiency of on-going delivery systems and cost recovery in Mectizan (ivermectin, MSD) treatment for onchocerciasis are reviewed.
The search is on for an effective system of Mectizan delivery, involving drug procurement, delivery from port to districts and distribution to eligible persons, which can be sustained by the endemic countries for many years.
The mechanisms for procuring and clearing the drug at the ports, and the drug's integration into the existing delivery systems of each national health service, need to be improved.
Although large-scale treatments by mobile teams or community-based methods evidently achieve high and satisfactory rates of coverage, they also incur high recurrent costs which have to be covered by external partners and are not sustainable by national health services.
Cost-sharing is considered an important factor in a sustainable delivery system and community-directed treatment, in which the community shares the cost and ownership of local distribution and is empowered to design and implement it, is likely to be more cost-effective and sustainable.
Mots-clés Pascal : Onchocercose, Filariose, Nématodose, Helminthiase, Parasitose, Infection, Système distribution, Antiparasitaire, Ivermectine, Chimiothérapie, Réseau distribution, Traitement, Coût, Coût distribution, Homme, Burkina Faso, Afrique, Méthode, Programme sanitaire, Dispensation médicament, Economie santé, Organisation santé
Mots-clés Pascal anglais : Onchocerciasis, Filariosis, Nematode disease, Helminthiasis, Parasitosis, Infection, Distribution system, Parasiticid, Ivermectin, Chemotherapy, Distribution network, Treatment, Costs, Distribution cost, Human, Burkina Faso, Africa, Method, Sanitary program, Drug dispensation, Health economy, Public health organization
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0314111
Code Inist : 002B05E03B4C. Création : 27/11/1998.